Department of Dermatology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, Xinjiang Uyghur Autonomous Region, China.
J Immunol Res. 2022 Jul 15;2022:7420330. doi: 10.1155/2022/7420330. eCollection 2022.
This work was to investigate mechanism by which mir-22 targeting nod-like receptor protein 3 (NLRP3) inflammasome affected activity of human skin malignant melanoma (MM) A375 cells. Twenty-four mice were rolled into a control group (Group X) and an experimental group (Group Y) randomly. Without treatment in Group X, Group Y established MM model. After cell transfection, the mice were divided into group A (blank group), group B (negative group), group C (miR-22 mimics group), group D (miR-22 inhibitor group), and group E (miR-22 inhibitor+siNLRP3 group). The results were summarized as follows. The level of miR-22 mRNA in Group Y was obviously lower than that in Group X, and levels of NLRP3 and caspase-1 mRNA and NLRP3 and caspase-1 protein in Group Y were greatly higher than those in Group X ( < 0.05). The mRNA levels of miR-22 mRNA in group C were much higher in contrast to those in group A, and the mRNA levels of NLRP3 and caspase-1 were lower. The contrast results in group D and group A were the opposite, < 0.05. The levels of NLRP3 and caspase-1 proteins in group C were greatly elevated, and those in group D were decreased compared with those in group A ( < 0.05). Therefore, miR-22 may target and inhibit the activation of the NLRP3 inflammasome to reduce the activity of cutaneous malignant melanoma A375 cells.
本研究旨在探讨 miR-22 靶向核苷酸结合寡聚化结构域样受体蛋白 3(NLRP3)炎症小体影响人皮肤恶性黑素瘤(MM)A375 细胞活性的机制。将 24 只小鼠随机分为对照组(X 组)和实验组(Y 组)。X 组不做任何处理,Y 组建立 MM 模型。转染细胞后,将小鼠分为 A 组(空白组)、B 组(阴性组)、C 组(miR-22 模拟物组)、D 组(miR-22 抑制剂组)和 E 组(miR-22 抑制剂+siNLRP3 组)。结果如下。Y 组 miR-22mRNA 水平明显低于 X 组,Y 组 NLRP3 和 caspase-1mRNA 及 NLRP3 和 caspase-1 蛋白水平明显高于 X 组( < 0.05)。与 A 组相比,C 组 miR-22mRNA 水平明显升高,NLRP3 和 caspase-1mRNA 水平明显降低( < 0.05)。与 A 组相比,D 组 miR-22mRNA 水平明显降低,NLRP3 和 caspase-1mRNA 水平明显升高( < 0.05)。与 A 组相比,C 组 NLRP3 和 caspase-1 蛋白水平明显升高,D 组 NLRP3 和 caspase-1 蛋白水平明显降低( < 0.05)。综上所述,miR-22 可能通过靶向抑制 NLRP3 炎症小体的激活来降低皮肤恶性黑素瘤 A375 细胞的活性。